1. Medtech Insight
  2. >>Policy & Regulation

Expanding Medicare Coverage For Digital Health Technologies Gains Support

 
• By Marion Webb

AdvaMed outlined recommendations to expand Medicare coverage for digital health tech. Several lawmakers are also pushing to retain flexibilities after the COVID-19 public health emergency expires.

Telemedicine

While the COVID-19 pandemic has spurred a seismic shift in terms of adoption of digital health technologies, questions persist around whether some of the flexibilities enacted during the pandemic will become permanent.

In a 10 March webinar hosted by AdvaMed, representatives of the medtech industry advocacy group and Washington, DC, health policy consulting group CapView Strategies outlined their recommendations on how the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.